Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

TIP 63: Medications for Opioid Use Disorder

About this resource:

HHS Non-systematic Review

Source: Substance Abuse and Mental Health Services Administration, 2019

Last Reviewed: July 2021

Workgroups: Substance Use Workgroup

Read more about this resource

Objectives related to this resource (3)

Reduce drug overdose deaths — SU‑03
LHI label
Getting worse
Reduce the proportion of people who misused prescription drugs in the past year — SU‑12
Little or no detectable change
Reduce the proportion of people who had drug use disorder in the past year — SU‑15
Little or no detectable change

Suggested Citation

1.

Substance Abuse and Mental Health Services Administration. (2021). TIP 63: Medications for Opioid Use Disorder. Retrieved from https://store.samhsa.gov/product/tip-63-medications-opioid-use-disorder/pep21-02-01-002